| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Life Technologies Corp., (NASDAQ: LIFE) www.lifetechnologies.com - On November 21, 2008, Invitrogen Corporation and Applied Biosystems Inc announced the completion of their merger transaction. Effective November 24, 2008, the two companies merged to form a new company under the name, Life Technologies Corporation
Paradigm Biodevices is a Rockland, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ReviveHealth is a healthcare subscription membership that offers unique healthcare programs for individuals, employers, and associations. They provide access to virtual primary, urgent & pediatric care, physical & mental health therapy, with Rxs inclu...
Animal Dermatology Group is a veterinary dermatology specialty company with the worlds largest unified group of veterinary dermatology specialists engaged in the diagnosis and treatment of acute and chronic skin conditions in pets.